Drug Profile
N-Pentyl sparsomycin
Latest Information Update: 09 Oct 1996
Price :
$50
*
At a glance
- Originator Pharmachemie
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 09 Oct 1996 Discontinued-Preclinical for Cancer in Netherlands (Unknown route)